Microtubule associated protein-4 (MAP4) regulates early T cell signaling by controlling microtubule stability and CD3ζ-bearing nanovesicle dynamics. MAP4 also acts balancing earlier and late T cell activation events. 
INTRODUCTION
The recognition of an antigen peptide on the surface of an antigen presenting cell (APC) triggers a signaling cascade leading to the formation of a polarized and specialized structure called the IS (Huppa and Davis, 2003) . Its proper formation is tightly regulated by the interplay of the actin and tubulin cytoskeletons (Soares et al., 2013) . MT network is polarized at the IS due to the translocation of the MTOC towards the contact area, leading to the rearrangement of the tubulin cytoskeleton by polymerization of new MTs (Martin-Cofreces et al., 2014) .
MAPs are proteins that bind to MTs and regulate their dynamics, growth, catastrophe and association to other molecular complexes. MAP4 is the most abundant MAP in non-neuronal tissues. In vitro, MAP4 promotes MT assembly and stabilization (Nguyen et al., 1999; Nguyen et al., 1998) . Moreover, it has been involved in some physiological processes such as cilia formation (Ghossoub et al., 2013) or myotube organization (Mogessie et al., 2015) . Most studies regarding MAP4 have addressed its role in a cell division context, controlling the assembly of the mitotic spindle and the orientation of the centrosome (Chang et al., 2001; Samora et al., 2011) .
In this work, we assessed MAP4 role in T cell activation and polarization. We have identified a new role of MAP4 in CD3ζ-bearing nanovesicle dynamics at the IS and T cell activation.
RESULTS AND DISCUSSION

MAP4 regulates MTs stabilization and MTOC translocation at IS.
In order to assess MAP4 location in CD4+ T cells during IS formation, MAP4 was immunostained in Jurkat T cells conjugated with SEE-pulsed Raji B cells (SEE-APCs) (Fig. 1A) . MAP4 staining was similar to that of α-tubulin, decorating the MTOC.
MAP4 dynamics was assessed upon T cell-APC contact formation in Jurkat T cells cotransfected with rodent MAP4 coupled to GFP and α-tubulin-mCherry and conjugated with SEE-APCs. Time-lapse confocal microscopy revealed a similar behavior for both proteins ( Fig.S1 and Movie S1).
In most systems, MAP4 appears mainly co-localized with MTs (Chang et al., 2001;  concentrated around the MTOC. These results suggest that, in T cells, MAP4 may be important for the assembly of new MTs during IS formation. To address this, we first measured the ability of MTs to reassemble in control cells or cells depleted of MAP4 using specific siRNAs (MAP4KD) (Fig. 1B) . T cells were treated with nocodazole (8 µM) to fully depolymerize MTs, and their re-assembly assessed upon washout of the inhibitor. Most MAP4KD cells displayed depolymerized tubulin, which concentrated around the nucleus (Fig 1C) , indicating that MAP4 is required for the reassembly of MTs. To assess whether MAP4 participates in MT stabilization in response to TCR signals, we studied the de-tyrosination (Glu) of α-tubulin, a MT stability marker observed upon TCR activation, in T cells. Interestingly, the increase of de-tyrosinated tubulin upon TCR triggering was prevented in MAP4KD cells (Fig. 1D) . However, no changes in the overall efficiency of conjugate formation were detected (Fig. 1E ).
Together, these results indicate that MAP4 is an important mediator of MT assembly, likely by controlling MT stability, in response to signals emanating from the IS. 
MAP4 modulates TCR signaling and dynamics of signaling nanovesicles at the IS.
To ascertain whether the defects in the tubulin cytoskeleton due to MAP4 decrease can lead to the impaired signaling at the T cell receptor (TCR signalosomes), we studied the pattern of phosphorylation of downstream molecules of the TCR such as CD3ζ, LAT, PKCθ and ERK, in SEE-activated control and MAP4KD Jurkat T cells ( Fig. 2A) .
Quantitative analysis revealed a decrease in CD3ζ, LAT-Y191 and ERK phosphorylation and a slight decrease in LAT-Y132 phosphorylation in MAP4KD cells ( Fig. 2B and S2 ). However, no changes in PKCθ phosphorylation were detected ( To assess the mechanism by which MAP4 regulates TCR early signaling, the dynamics of CD3ζ-bearing nanovesicles was analyzed by total internal reflection microscopy (TIRFm) in control and MAP4KD Jurkat T cells transfected with CD3ζ-Cherry and activated in a stimulatory surface coated with anti-CD3/CD28 antibodies. The analysis of the vesicle tracks showed a significant defect in the movement and displacement of the vesicles ( Fig. 2E and Movie S2-S3). Surface levels analysis of TCRαβ and CD3ε in MAP4KD cells showed no differences (Fig. 2F ). TCR sustained signal is highly dependent on its cycle of degradation and recycling (Monjas et al., 2004) . However, no differences were detected either in terms of the internalization of TCR/CD3ε molecules or in their general recycling in control and MAP4KD cells upon activation (Fig. 2G) .
Our results suggest that the impairment in TCR early signaling is more likely due to defects in the polarized action of CD3ζ-bearing nanovesicles rather than differences in the whole rate of internalization/recycling of the TCR. Moreover, it has been proved that a pool of active phoshorylated-CD3ζ exists in the vesicular compartment, being crucial for sustaining TCR signaling and proper T cell activation (Yudushkin and Vale, 2010) . Accordingly, although MAP4 reduction would probably not affect to the initial triggering of TCR signaling, it leads to a blockade of the movement of CD3ζ-nanovesicle pool (possibly phosphorylated), avoiding its mobilization towards the fusion areas and therefore the maintenance of TCR signaling. On the other hand, since
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MAP4 absence enhances late activation markers and promotes diacylglycerol (DAG) imbalance.
To determine whether inhibition of TCR signaling by MAP4 depletion affects TCRdependent gene expression or cytokine secretion, we assessed the mRNA pattern of expression of later activation markers in control or MAP4KD Jurkat T cells activated with SEE-APCs. A significant increase in IL2 and CD69 mRNA expression was detected in MAP4-silenced cells (Fig. 3A) . Correspondingly, similar results were obtained by analyzing IL2-secretion in activated Jurkat T cells or primary T lymphoblasts (Fig. 3B) . The same trend was detected when analyzing CD69 surface expression in activated Jurkat T cells (Fig. 3C ) and in primary T lymphoblasts (Fig.   S3A ).
To explain this increase of late activation markers, we explored additional signaling intermediates downstream of the TCR. A significant increase in PLCγ1 phosphorylation in MAP4KD cells was observed either in Jurkat T cells (Fig. 3D ) or in primary T lymphoblasts (Fig. 3E) . To functionally analyze its relevance, we examined the production of DAG by using PKCθ-C1-GFP. Quantitative analysis of its accumulation at the IS revealed a significant increase in the DAG production in MAP4KD cells (Fig.   3F ). PKCθ whole protein accumulation was unaffected in MAP4KD cells (Fig. S3B) .
Since MAP4KD cells activated by SEE-APCs showed an increase in NFAT and NF-κB transcriptional activity (Fig. 3G) , as well as in nuclear NF-κB (p65) upon TCR activation (Fig. S3C) , it is possible that PKCθ is more active, by a CD28-mediated increased turn-over between plasma membrane and cytoskeleton moieties (Huang et al., 2002) .
Although PLCγ1 clustering depends on LAT, PLCγ1 phosphorylation occurs prior to LAT-Y132 phosphorylation (Houtman et al., 2005) and it is dependent on Itk (Andreotti et al., 2010) . In fact, our results show no differences in PLCγ1 clustering in MAP4KD cells (Fig. S3D) . Therefore, MAP4 might be regulating PLCγ1-Itk spatial association.
Alternatively, the spatial regulation of CD148, the phosphatase responsible of PLCγ1 In addition, local production of DAG by phosphorylated PLCγ1 (Y783) can control MTOC localization close to the plasma membrane upon TCR activation (Quann et al., 2009 ). Our data suggest that the delay in MTOC translocation boosts the production of DAG to overcome this defect in MAP4KD cells. In accordance, the blockade of MTOC translocation, by disruption of AKP450 centrosomal localization or over-expression of HDAC6, also increased DAG production (Fig. S4) . Therefore, MAP4 acts as balancer for T cell activation and its final functional outcome.
MATERIALS AND METHODS
Cells
The human Jurkat-derived T cell line E6.1 (Vβ8+ TCR) and the lymphoblastoid B-cell line Raji were from ATCC. Human Cell lines were tested for mycoplasm contamination and authenticated through specific surface markers. Human peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats obtained from healthy donors as described (Mittelbrunn et al., 2011) . These studies were performed according to the principles of the Declaration of Helsinki and approved by the local Ethics Committee for Basic Research at the Hospital La Princesa (Madrid); informed consent was obtained from all human volunteers.
Antibodies and reagents
Antibodies used in this study: anti-CD3ζ-pY83 (ab68236; 1:1000), anti-CD3ζ (CGUACGCGGAAUACUUCGA). For transfection and qPCR, we followed protocols as described (Blas-Rus et al., 2016) . Primers sequence is indicated in Supplemental Table S1 .
T cell activation, cell lysis, nuclear/cytoplasmic fractioning and immunoblotting
For antigen stimulation, Jurkat E6.1 cells were mixed with Raji B cells (1:5) pre-pulsed with 0.5µg/ml SEE (30 min) and allowed to conjugate for the indicated times. Then, cells were lysed and immunoblot was performed as described (Blas-Rus et al., 2016) .
For nuclear/cytoplasmic fractioning, cells were lysed, spun at 650 x g (15 min/4ºC) and supernatant was recovered as the cytoplasmic fraction. Nuclear fraction was washed once with lysis buffer without NP-40 and lysed in loading buffer.
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Cell conjugate formation, immunofluorescence and TIRFm
Cell conjugation preparation, immunoflorescence protocol, confocal and TIRFm imaging were performed as described (Blas-Rus et al., 2016) . Specific conditions are described in corresponding figure legends. For MAP4 staining cells were fixed in 100% methanol (5 min/-20ºC) followed by PFA 2% (10 min/RT). Images were processed, quantified with Adobe Photoshop CS and ImageJ. MTOC translocation experiments images were analyzed with Imaris software.
Nocodazol treatment
Cells were treated with vehicle (DMSO) or nocodazol (8 µM) for 1 h, washed twice and let to recover for 1.5 h.
ELISA, flow cytometry and TCR internalization and recycling measurement
Jurkat E6 For TCR internalization measurement, Jurkat E6.1 cells were stimulated with anti-CD3ε (HIT3α) and CD28 antibodies-coated plates for indicated times. Cells were then fixed and stained for CD3ε (UCHT1). Cells were analyzed with a FACs Canto II Cytometer (BD) and FlowJo. Recycling experiments were performed as described (Finetti et al., 2009) . Stimulation was performed with anti-CD3/anti-CD28 coated plates.
Luciferase assay
Cells were transfected with NFAT/NFκB-Luciferase construction plus Renilla plasmid (2µg + 0.4 µg per 10 6 of cells, respectively) and activated with SEE-pulsed-Raji B cells (24 h). Protocol was performed accordingly to manufacturer instructions (Promega).
Measurements were normalized to Renilla levels and protein quantity. 
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Statistical analysis
